Press Releases
Continuing Health Care Solutions, Inc. (CHS) Receives $43.3 Million Credit Facility
February 15, 2019
Benesch client, Continuing Health Care Solutions, Inc. (CHS) has received a $43.3 million term loan and line of credit from Oxford Finance LLC. These funds were used to purchase and provide working capital for eight long-term care facilities in Ohio from the Zandex Group. CHS was established over six years ago by long-term industry veterans and has since become the premier provider of long-term care services in Ohio and neighboring regions. The acquisition of the Zandex portfolio enables the CHS team to deliver best in care services to markets in which they have an established footprint. The Benesch team included Joe Tegreene, Joel Pentz, Harry Brown, Chris Matgouranis and Janelle Gasbarino.
Latest News
Benesch Recognized as Leading Law Firm by Chambers USA 2026 with Record Growth in National and Regional Rankings
Benesch has once again been recognized by Chambers and Partners as one of the nation’s leading law firms in its Chambers USA 2026 guide, with 43 Benesch attorneys and 21 practice areas ranked.
Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First
Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.
Benesch Represents Tribeca Strategic Acquisition Corporation in $140 Million Public Offering
Benesch represented Tribeca Strategic Acquisition Corporation (Nasdaq: BIDWU) in its $140 million initial public offering on the Nasdaq Global Market. …
Benesch Named Recipient of AHLA 2026 Top Honors for Sixth Consecutive Year
Benesch is pleased to announce that it has been named a recipient of the American Health Law Association’s (AHLA) 2026 …